Evorel Conti Patches
*Company:
Theramex Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 02 October 2024
File name
ie-pl-evorel-conti-0011.pdf
Reasons for updating
- Change to section 3 - how to take/use
- Change to section 6 - date of revision
Updated on 02 October 2024
File name
ie-spc-evorel-conti-0011.pdf
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 23 September 2022
File name
ie-evorel conti-pl clean.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
Updated on 23 September 2022
File name
ie-spc-evorel conti clean.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 15 July 2022
File name
IE-pl-50-clean-0008.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
Updated on 22 January 2021
File name
ie-pl-conticlean.pdf
Reasons for updating
- XPIL Created
Updated on 22 January 2021
File name
ie-pl-conticlean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 22 January 2021
File name
ie-spc-conticlean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 29 April 2020
File name
ie-pl-clean-conti.pdf
Reasons for updating
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 22 January 2020
File name
ie-spc-clean Conti.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 22 January 2020
File name
ie-pl-clean Conti.pdf
Reasons for updating
- New PIL for new product
Theramex Ireland Limited
Address:
Sloane Square House, 1 Holbein Place, Belgravia, London SW1W 8NSMedical Information E-mail:
Medinfo.ie@theramex.comTelephone:
+44 (0) 20 3962 5555Medical Information Direct Line:
01 903 6075